Former CEO Pleads Guilty to Causing the Distribution of Adulterated and Misbranded Medical Devices Intended to Treat Migraine Headaches

FDA OCI, Mark Wright, Dolor Technologies, medical device, SphenoCath, migraine, headaches, nerve, block, no FDA clearance, approval, adulterated, misbranded, investigational, studies, sphenopalatine ganglion, SPG,

Source: Office of Criminal Investigations (OCI) Press Releases - October 16, 2023 Category: Medical Law Authors: DOJ Source Type: news